Organigram Global, Inc. (OGI)
1.60
-0.01
(-0.62%)
USD |
NASDAQ |
Jan 20, 16:00
1.60
0.00 (0.00%)
After-Hours: 20:00
Organigram Global EPS Diluted (Quarterly): -0.2055 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tilray Brands, Inc. | -0.4072 |
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.3157 |
| Lexaria Bioscience Corp. | -0.0746 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.56M |
| Revenue (Quarterly) | 58.13M |
| Total Expenses (Quarterly) | 85.69M |
| Enterprise Value | 162.10M |
| Gross Profit Margin (Quarterly) | 0.52% |
| Profit Margin (Quarterly) | -47.42% |
| Earnings Yield | -10.14% |
| Normalized Earnings Yield | -21.27 |